Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma

  • Authors:
    • Jing Zhu
    • Feng Jiang
    • Hong-Bing Ni
    • Ming-Bing Xiao
    • Bu-You Chen
    • Wen-Kai Ni
    • Cui-Hua Lu
    • Run-Zhou Ni
  • View Affiliations

  • Published online on: October 31, 2012     https://doi.org/10.3892/etm.2012.783
  • Pages: 89-94
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

γ‑glutamyl transferase isoenzyme II (GGT‑II) is a sensitive biomarker of hepatocellular carcinoma (HCC). However, numerous disadvantages of the traditional manual method affected its application. The commercial kit provided a convenient and fast method for the determination of GGT‑II levels. The purposes of the present study were to compare the reproducibility and sensitivity between the manual and commercial kit methods and to evaluate the diagnostic efficiency for HCC with the combined analysis of GGT‑II, α‑L‑fucosidase (AFU) and α‑fetoprotein (AFP). In patients with various liver diseases (HCC, liver cirrhosis and chronic hepatitis) and normal subjects, GGT‑II was detected by manual and commercial polyacrylamide gel electrophoresis (PAGE). The levels of AFU and AFP were assayed by colorimetry and a chemiluminescence immunoassay, respectively. The commercial PAGE had equal diagnostic efficiency with traditional manual PAGE and no significant differences were observed in intra‑ and average‑gel reproducibility and GGT‑II sensitivities between the manual and commercial PAGE (P>0.05). The incidence of GGT‑II detected by commercial PAGE in HCC patients was 84.1% and <8% in benign liver disease. The levels of AFU and AFP in the benign liver diseases and normal subjects were lower than those in HCC. According to the cut‑off value obtained by receiver operating characteristic curves, a total of 56.6 and 59.3% of HCC patients (64 out of 113 and 67 out of 113) had AFU >636.5 µmol/l h and AFP >44.0 µg/l, respectively. There were no significant correlations between GGT‑II and AFU or AFP. Combined detection of GGT‑II with AFU or AFP increased the diagnostic sensitivity to 92.9 and 93.8%, respectively. These results suggest that commercial PAGE provides a simple and reproducible method for GGT‑II detection. Combined determination of GGT‑II with AFU or AFP exhibited superior sensitivity and specificity for the diagnosis of HCC.
View Figures
View References

Related Articles

Journal Cover

January 2013
Volume 5 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu J, Jiang F, Ni H, Xiao M, Chen B, Ni W, Lu C and Ni R: Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma. Exp Ther Med 5: 89-94, 2013
APA
Zhu, J., Jiang, F., Ni, H., Xiao, M., Chen, B., Ni, W. ... Ni, R. (2013). Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma. Experimental and Therapeutic Medicine, 5, 89-94. https://doi.org/10.3892/etm.2012.783
MLA
Zhu, J., Jiang, F., Ni, H., Xiao, M., Chen, B., Ni, W., Lu, C., Ni, R."Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma". Experimental and Therapeutic Medicine 5.1 (2013): 89-94.
Chicago
Zhu, J., Jiang, F., Ni, H., Xiao, M., Chen, B., Ni, W., Lu, C., Ni, R."Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma". Experimental and Therapeutic Medicine 5, no. 1 (2013): 89-94. https://doi.org/10.3892/etm.2012.783